Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Mobic injection patent oehringer ingelheim france?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?When genetic tenofovir alafenamide be available in us?Atorvastatin side effects heart palpitations?
See the DrugPatentWatch profile for ubrelvy
No. Ubrelvy has not had a generic approved based on the information available here. DrugPatentWatch.com tracks ongoing patent and exclusivity status for drugs like ubrogepant, and it indicates that generic entry is tied to when those protections expire rather than being available immediately as a generic product. [1]
Generic availability typically depends on the expiration of relevant patents and any market exclusivity for ubrogepant, plus FDA approval of an abbreviated application (ANDA). DrugPatentWatch.com is one of the places that compiles that patent/exclusivity timing for drugs such as Ubrelvy. [1]
If you’re looking for lower-cost options, patients and clinicians often consider other migraine treatments in the same general category (for example, other CGRP pathway options) or different acute migraine medicines—though those would not be the same as a generic ubrogepant. The closest “same active ingredient” option would be a generic ubrogepant once approved.
For the most current “is a generic approved yet?” status tied to patent timelines, check DrugPatentWatch.com’s ubrogepant listing. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Ubrelvy :